| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.08 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.053 | 0.09 |